164 related articles for article (PubMed ID: 37952244)
1. Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report.
Goldberg JF; Hyun G; Ness KK; Dixon SB; Towbin JA; Rhea IB; Ehrhardt MJ; Srivastava DK; Mulrooney DA; Hudson MM; Robison LL; Jefferies JL; Rohatgi A; Armstrong GT
J Natl Cancer Inst; 2024 Mar; 116(3):408-420. PubMed ID: 37952244
[TBL] [Abstract][Full Text] [Related]
2. Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
Wu F; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Juonala M; Magnussen CG
JAMA; 2024 Jun; 331(21):1834-1844. PubMed ID: 38607340
[TBL] [Abstract][Full Text] [Related]
3. The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study.
Hammoud RA; Liu Q; Dixon SB; Onerup A; Mulrooney DA; Huang IC; Jefferies JL; Rhea IB; Ness KK; Ehrhardt MJ; Hudson MM; Ky B; Bhakta N; Sapkota Y; Yasui Y; Armstrong GT
Lancet Oncol; 2024 Jun; 25(6):811-822. PubMed ID: 38821086
[TBL] [Abstract][Full Text] [Related]
4. Associations of dietary iron intake with cardiovascular disease risk and dyslipidemia among Chinese adults.
Cui M; Wu H; Zhang H; Wei L; Qi X
Lipids Health Dis; 2024 Mar; 23(1):67. PubMed ID: 38431652
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
Duncan MS; Vasan RS; Xanthakis V
J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Prevalence of Dyslipidemia Among Adult Population of Tehran: The Tehran Cohort Study.
Shafiee A; Kazemian S; Jalali A; Alaeddini F; Saadat S; Masoudkabir F; Tavolinejad H; Vasheghani-Farahani A; Arita VA; Sadeghian S; Boroumand M; Karimi A; Franco OH
Arch Iran Med; 2024 Feb; 27(2):51-61. PubMed ID: 38619028
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and cardiovascular disease in cancer survivors.
Ueno K; Kaneko H; Suzuki Y; Okada A; Matsuoka S; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Kamiya K; Ako J; Node K; Yasunaga H; Komuro I
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1062-1071. PubMed ID: 38515400
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.
Lu Y; Zhang H; Lu J; Ding Q; Li X; Wang X; Sun D; Tan L; Mu L; Liu J; Feng F; Yang H; Zhao H; Schulz WL; Krumholz HM; Pan X; Li J;
JAMA Netw Open; 2021 Sep; 4(9):e2127573. PubMed ID: 34586366
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia paradox: Analysis from the veterans exercise testing study.
Vainshelboim B; Myers J
PLoS One; 2023; 18(7):e0287923. PubMed ID: 37467298
[TBL] [Abstract][Full Text] [Related]
11. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia and its association with meibomian gland dysfunction.
Braich PS; Howard MK; Singh JS
Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
[TBL] [Abstract][Full Text] [Related]
14. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
Tóth PP; Potter D; Ming EE
J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
[TBL] [Abstract][Full Text] [Related]
16. Metal mixture exposures and serum lipid levels in childhood: the Rhea mother-child cohort in Greece.
Yim G; Margetaki K; Romano ME; Kippler M; Vafeiadi M; Roumeliotaki T; Bempi V; Farzan SF; Chatzi L; Howe CG
J Expo Sci Environ Epidemiol; 2024 May; ():. PubMed ID: 38698271
[TBL] [Abstract][Full Text] [Related]
17. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
18. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
Pennell P; Leclercq B; Delahunty MI; Walters BA
Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
